BUY Krishna Institute of Medical Sciences Limited — Rakesh Bansal
byRakesh BansalHorizon: NA (inferred Swing (≤2wk))24 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·17 Sept · 1w ago
KIMS enters O&M agreement to manage 183-bed Trust Hospital in Kakinada, Andhra Pradesh
NewsCnbc-Tv18·10 Sept · 2w ago
Krishna Institute of Medical Sciences Ltd entered into an Operations and Management Agreement with Sarvottam Health Care Private Limited.
BSE · Company Update·10 Sept · 2w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Krishna Institute of Medical Sciences
- BUY — Sahi Research13 Nov 2026 · ~2 weeks · target ₹765 · Active
- BUY — ICICI Securities6 Nov 2026 · ~1 year · target ₹885 · Active
- BUY — Jigar S Patel, Anand Rathi19 Oct 2026 · ~3 months · target ₹800 · Active
- BUY — HSBC Securities9 Oct 2026 · ~1 year · target ₹865 · Active
- BUY — Goldman Sachs1 Oct 2026 · ~1 year · target ₹1,000 · Active
More from Rakesh Bansal
- BUY Agi Infra13 Nov 2026 · ~3 months · target ₹360 · Active
- BUY Reliance Industries13 Nov 2026 · Next day · target ₹1,375 · Active
- BUY Hero MotoCorp13 Nov 2026 · ~2 weeks · target ₹5,497 · Active
- BUY Edelweiss Financial Services13 Nov 2026 · ~2 weeks · target ₹147 · Active
- BUY Dalmia Bharat Sugar and Industries13 Nov 2026 · ~2 weeks · target ₹550 · Active

